Varicose veins are associated with an increased risk of mitral valve regurgitation: a nationwide population-based cohort study

被引:2
作者
Lee, Meng-Lin
Chou, Wan-Yun [3 ]
Kao, Yi-Wei [4 ,5 ]
Chen, Ming-Chih [4 ,6 ]
Shia, Ben -Chang [4 ,6 ]
Lee, Pei-Shyuan [7 ,8 ]
Chen, Thay-Hsiung [1 ]
Lin, Ting -Yuan [9 ]
Huang, Shih-Yu [1 ,10 ,11 ]
Su, Yen -Bo [1 ,2 ,12 ]
Chiu, Wei-Che [1 ,3 ,11 ,13 ,14 ]
机构
[1] Cathay Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan
[2] Cathay Gen Hosp, Dept Surg, Div Cardiovasc Surg, Hsinchu Branch, Hsinchu, Taiwan
[3] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan
[4] Fu Jen Catholic Univ, Artificial Intelligence Dev Ctr, New Taipei City, Taiwan
[5] Ming Chuan Univ, Dept Appl Stat & Informat Sci, Taoyuan City, Taiwan
[6] Fu Jen Catholic Univ, Grad Inst Business Adm, Coll Management, New Taipei City, Taiwan
[7] Cathay Gen Hosp, Dept Family Med, Taipei, Taiwan
[8] Cathay Gen Hosp, Dept Family Med, Neihu Clin, Taipei, Taiwan
[9] Taipei City Hosp, Dept Internal Med, Div Cardiol, Renai Branch, Taipei, Taiwan
[10] Cathay Gen Hosp, Dept Cardiovasc Ctr, Div Cardiac Electrophysiol, Taipei, Taiwan
[11] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan
[12] Cathay Gen Hosp, Dept Cardiovasc Ctr, Div Gen Cardiol, Taipei, Taiwan
[13] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan
[14] Cathay Gen Hosp, Dept Psychiat, 280, Sec 4, Ren Ai Rd, Taipei 10630, Taiwan
关键词
Varicose veins; Mitral valve insufficiency; National health programs; CHRONIC VENOUS DISEASE; POLYMORPHISMS; PROLAPSE; EPIDEMIOLOGY; INSIGHTS;
D O I
10.23736/S0392-9590.23.05053-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Varicose veins (VV) and mitral valve regurgitation (MR) are both common diseases. The aim was to investigate whether VV are associated with an increased risk of MR. Methods: We conducted a nationwide cohort study to assess the association between VV and risk of developing MR. Drawn from the Taiwan National Health Insurance Research Database (NHIRD), the records of 56,898 patients with VV (the VV cohort) and 56,898 propensity score-matched patients without VV (the non-VV cohort) in the years 2007 to 2015 were identified. Follow-up duration was calculated from the date of entry in the cohort until the occurrence of a first MR diagnosis, death, or the end of the observation period (December 31, 2015), whichever occurred first. Hazard ratios (HRs) and accompanying 95% confidence intervals (CIs) derived from the Cox proportional hazards model were used to estimate the association between VV and MR risks. Results: After multivariable adjustment, VV was associated with an increased risk of MR (adjusted HR, 1.63; 95% CI: 1.52-1.74). Notably, significant associations between VV and MR risk were evident in both genders and in all age groups. A trend of significant increase of MR risk was also observed with increasing frequency of annual clinical visits for VV. Within the VV cohort, the subgroup of MR presence had higher incidences of atrial fibrillation, heart failure, valve-related surgeries, and mortality (P<0.001). Conclusions: This population-based cohort study revealed that VV was associated with an increased risk of MR in a Taiwanese population. Vigilance of MR existence should be emphasized in patients of VV due to its potentially poor long-term outcomes.
引用
收藏
页码:352 / 361
页数:10
相关论文
共 31 条
  • [1] Mitral valve prolapse
    Althunayyan, Aeshah
    Petersen, Steffen E.
    Lloyd, Guy
    Bhattacharyya, Sanjeev
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (01) : 43 - 51
  • [2] Associations of rs3918242 and rs2285053 MMP-9 and MMP-2 polymorphisms with the risk, severity, and short- and long-term complications of degenerative mitral valve diseases: a 4.8-year prospective cohort study
    Balistreri, Carmela Rita
    Allegra, Alberto
    Crapanzano, Floriana
    Pisano, Calogera
    Triolo, Oreste Fabio
    Argano, Vincenzo
    Candore, Giuseppina
    Lio, Domenico
    Ruvolo, Giovanni
    [J]. CARDIOVASCULAR PATHOLOGY, 2016, 25 (05) : 362 - 370
  • [3] The epidemiology of chronic venous insufficiency and varicose veins
    Beebe-Dimmer, JL
    Pfeifer, JR
    Engle, JS
    Schottenfeld, D
    [J]. ANNALS OF EPIDEMIOLOGY, 2005, 15 (03) : 175 - 184
  • [4] Mechanisms of disease:: Chronic venous disease
    Bergan, John J.
    Schmid-Schoenbein, Geert W.
    Smith, Philip D. Coleridge
    Nicolaides, Andrew N.
    Boisseau, Michel R.
    Eklof, Bo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (05) : 488 - 498
  • [5] Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review
    Bharath, Vighnesh
    Kahn, Susan R.
    Lazo-Langner, Alejandro
    [J]. BLOOD, 2014, 124 (08) : 1242 - 1250
  • [6] Cameli M, 2017, IJC HEART VASC, V17, P17, DOI 10.1016/j.ijcha.2017.08.003
  • [7] Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
    Chang, Shang-Hung
    Chou, I-Jun
    Yeh, Yung-Hsin
    Chiou, Meng-Jiun
    Wen, Ming-Shien
    Kuo, Chi-Tai
    See, Lai-Chu
    Kuo, Chang-Fu
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (13): : 1250 - 1259
  • [8] Geographic variation in the age- and gender-specific prevalence and incidence of epilepsy: Analysis of Taiwanese National Health Insurance-based data
    Chen, Chih-Chuan
    Chen, Li-Sheng
    Yen, Ming-Fang
    Chen, Hsiu-Hsi
    Liou, Horng-Huei
    [J]. EPILEPSIA, 2012, 53 (02) : 283 - 290
  • [9] Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan
    Cheng, Ching-Lan
    Kao, Yea-Huei Yang
    Lin, Swu-Jane
    Lee, Cheng-Han
    Lai, Ming Liang
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (03) : 236 - 242
  • [10] Chien H.-C., 2016, JAMA ONCOL, V2, P1317, DOI [DOI 10.1001/jamaoncol.2016.4792, DOI 10.1001/JAMAONCOL.2016.4792]